Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis

Pancreatic Ductal AdenoCarcinoma (PDAC) represents about 90% of pancreatic cancers. It is one of the most aggressive cancer, with a 5-year survival rate below 10% due to late diagnosis and poor therapeutic efficiency. This bad prognosis thus encourages intense research in order to better understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Liot, Sophie, El Kholti, Naïma, Balas, Jonathan, Genestier, Laurent, Verrier, Bernard, Valcourt, Ulrich, Lambert, Elise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302691/
https://www.ncbi.nlm.nih.gov/pubmed/34302028
http://dx.doi.org/10.1038/s41598-021-94566-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302691/
https://www.ncbi.nlm.nih.gov/pubmed/34302028
http://dx.doi.org/10.1038/s41598-021-94566-x

Ejemplares similares